Table 1.
Post-COVID patients. Baseline characteristics.
| Anthropometrics | Sleep disturbances | ||
|---|---|---|---|
| Age (years) | 47 ± 15 | More sleep | 23 (30) |
| Female | 55 (71) | Less sleep | 10 (13) |
| Male | 22 (29) | Unrefreshing sleep | 9 (12) |
| Weight (kg) | 88 ± 24 | Weight change | 10 (13) |
| BMI (kg/m2) | 30 ± 7 | PFT | |
| Acute COVID | FEV1 | 3.1 ± 0.8 | |
| Hospitalized | 14 (18) | Predicted FEV1 (%) | 96 ± 16 |
| O2 requirement | 12 (16) | FVC | 4.0 ± 1.1 |
| Ventilator | 2 (2.6) | Predicted FVC (%) | 93 ± 16 |
| Any medication | 14 (18) | DLCOcSB | 22 ± 5 |
| Antiviral | 7 (50) | Pred DLCOcSB (%) | 93 ± 16 |
| Corticosteroid | 12 (86) | Labs | |
| Immunotherapy | 1 (7.1) | Hgb | 14 ± 1.5 |
| Antibiotics | 2 (14) | Ferritin | 100 ± 147 |
| Plasma | 2 (14) | D dimer | 433 ± 424 |
| Time post COVID (days) | 214 ± 116 | IL-6 | 2.1 ± 1 |
| Reinfection | 13 (17) | CRP | 5.2 ± 6 |
| Long COVID symptoms | ESR | 9.3 ± 9.9 | |
| Fatigue | 71 (92) | ANA | 11 (14) |
| Dyspnea | 55 (71) | CCP | 15 ± 2 |
| Anosmia/ageusia | 19 (25) | RF | 15 ± 1.4 |
| Myalgias/arthralgias | 47 (61) | CK | 116 ± 108 |
| Mental fog | 51 (66) | TSH | 2.4 ± 1.2 |
| Dizziness/syncope | 27 (35) | AM cortisol | 13 ± 5.8 |
Values are mean ± SD or n (%).
BMI = body mass index; PFT = pulmonary function test; FEV1 = forced expiratory volume in the first second; FVC = forced vital capacity; DLCOcSB = diffusion capacity of the lung for carbon monoxide corrected for hemoglobin single breath; Hgb = hemoglobin; IL-6 = interleukin-6; CRP = C-reactive protein; ESR = erythrocyte sedimentation rate; ANA = antinuclear antibody; CCP = citrullinated peptide; RF = rheumatoid factor; CK = creatine kinase; TSH = thyroid stimulating hormone.